Medical/Pharmaceuticals

Synapse Biomedical Receives FDA Emergency Use Authorization for New System to Assist in Weaning Patients off of Ventilators During COVID-19 Pandemic

TransAeris® Diaphragm Pacing System (DPS) Could Cut Mechanical Ventilation Time by More Than 25%, Freeing up Vital Equipment, ICU Beds and Clinical Resources.  OBERLIN, Ohio, April 15, 2020 /PRNewswire/ -- Synapse Biomedical, Inc. ( www.synapsebiomedical.com) has received FDA Emergency Use Authori...

2020-04-15 18:00 3310

Australia to test COVID-19 vaccine

MELBOURNE, Australia, April 15, 2020 /PRNewswire/ -- The first COVID-19 vaccine to be tested outside of theUSA, and only the third vaccine clinical trial in the world, will be conducted byAustralia's largest Phase 1 clinical trials specialist Nucleus Network. As part of the urgent global race to...

2020-04-15 11:15 1503

Ortho's Total Antibody Test for COVID-19 Receives Emergency Use Authorization from FDA

RARITAN, North Jersey, April 15, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) today announced it granted Emergency Use Authorization to Ortho Clinical Diagnostics' total antibody assay for COVID-19—the VITROS® Immunodiagnostic Products Anti-SARS-CoV-2 Total Reagent Pack and Ca...

2020-04-15 10:42 1295

Lianhua Qingwen capsule (granule) was approved as an additional indication of COVID-19

SHIJIAZHUANG, China, April 15, 2020 /PRNewswire/ -- On April 14, 2020, Yiling Pharmaceutical announced that Yiling Pharmaceutical and its subsidiary Beijing Yiling Pharmaceutical had received the approval document of drug supplement application concerning the application for new indications of Li...

2020-04-15 05:55 7671

Iceland Provides a Picture of the Early Spread of COVID-19 in a Population With a Cohesive Public Health Response

REYKJAVIK, Iceland, April 15, 2020 /PRNewswire/ -- Scientists at deCODE genetics and colleaguesfrom Iceland's Directorate of Health and the National University Hospital today publish online in the New England Journal of Medicine a population-based study of the early spread ...

2020-04-15 05:24 2743

Updates - China Pharma Holdings, Inc. Reports Fiscal Year 2019 Financial Results

HAIKOU CITY, China, April 14, 2020 /PRNewswire/ -- China Pharma Holdings, Inc. (NYSE American: CPHI)  ("China Pharma," the "Company" or "We"), an NYSE American-listed corporation with a fully-integrated specialty pharmaceuticals subsidiary based inChina, today announced that it is re-issuing its ...

2020-04-15 04:30 16845

New ClinicAll Communicator App Supports Care Staff vs Corona

NEW YORK, April 15, 2020 /PRNewswire/ -- Decisive action is now needed to fight the coronavirus successfully. Most importantly, nursing staff needs protection and support. Everything that makes their work easier improves patient care, relieves pressure on hospitals and, in the end, helps saving l...

2020-04-15 01:04 1965

Chromatic Technologies' Scientists Join Fight Against COVID-19 Virus

American Thermal Instruments Lends Their Expertise COLORADO SPRINGS, Colorado, April 14, 2020 /PRNewswire/ -- Chromatic Technologies Inc. (CTI) has partnered with American Thermal Instruments (ATI) in Dayton, Ohio, to donate free-of-charge new printable temperature, tampering and authentication ...

2020-04-14 22:00 3832

Nucleus Network's 10 Step Guide to conducting Clinical Trials during a time of uncertainty

MELBOURNE, Australia, April 14, 2020 /PRNewswire/ -- A new white paper, Undertaking Phase I Clinical Trials inAustralia During a Time of Uncertainty , has been published by Nucleus Network (Nucleus),Australia's largest Phase 1 clinical trials provider....

2020-04-14 21:17 1054

Antengene Announces Dosing of First Patient in the ATG-019 (KPT-9274) Phase 1 Trial, a First-in-Class Dual Inhibitor, for Advanced Solid Tumors and Non-Hodgkin's Lymphoma

SHANGHAI and PHILADELPHIA, April 14, 2020 /PRNewswire/ -- Antengene announced today that it has dosed the first patient inTaiwan, China in its phase 1 open-label clinical trial of ATG-019 (KPT-9274), a dual inhibitor of both PAK4 and NAMPT. This trial is being conducted to evaluate the safety and...

2020-04-14 21:15 1488

Interlink Electronics Quadruples Production of Sensor Components for Ventilators During Critical Shortage

Patented Ring Sensor Used in Ventilators and Ultrasound Machines Allows Frontline Healthcare Workers to Use Equipment While Wearing Gloves, Further Protecting Themselves and Their Patients from the Spread of COVID-19 CAMARILLO, California, April 14, 2020 /PRNewswire/ -- Interlink Electronics, In...

2020-04-14 21:00 6478

Revolutionary Machine Learning Company Identifies Two Possible Treatments for Intractable Breast Cancer Type

Pattern Computer has received positive national lab results for combination therapy drug candidates targeting basal-like breast cancer REDMOND, Washington, April 14, 2020 /PRNewswire/ -- Pattern Computer®, Inc.  has received confirmation from Lawrence Berkeley National Laboratory that drug therap...

2020-04-14 20:27 2283

Merck Supports Jenner Institute to Reach First Milestone in Covid-19 Vaccine Manufacturing

- Recently developed manufacturing platform allows large-scale manufacturing - Joint team reduced process development time to two months from a year – a critical step to manufacturing Covid-19 vaccine at scale - "We have brought the future of vaccine manufacturing to the present," says Udit Batr...

2020-04-14 20:00 3409

Budget Direct Insurance Provides Customers Free Unlimited COVID-19 Teleconsultation Services

SINGAPORE, April 14, 2020 /PRNewswire/ -- Award-winning online insurer Budget Direct Insurance has launched complimentary COVID-19 Virtual Clinic teleconsultation services for all active annual insurance policyholders in partnership with MyDoc, a regional digita...

2020-04-14 14:15 4772

Great Minds from Medtech Gather at Medtec China; Discover Opportunities in the Rapidly Evolving Medical Device Market

SHANGHAI, April 14, 2020 /PRNewswire/ -- Medtec China 2020 will be held from September 14-16 at SWEECC Halls 2&4 this year, "MDiT Forum and Regulation Summit 2020" is also going to return, continuing to focus on "regulations, quality and technology," joining hands with medical device industry aut...

2020-04-14 13:08 4543

VUNO Med(R)-Fundus AI(TM) receives MFDS Regulatory Approval as Class III Medical Device

SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- VUNO, a member company of the Born2Global Centre, announced that their AI based screening solution for the fundus, VUNO Med®-Fundus AI™ is approved as a Class III medical device by the Ministry of Food and Drug Safety. VUNO Med®-Fundus AI™ is the f...

2020-04-14 07:36 1496

Shijiazhuang Yiling Pharmaceutical Co, Ltd. supports the battle against COVID-19 with "Lianhua Qingwen"

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Recently, Shijiazhuang Yiling Pharmaceutical Co, Ltd. announced that the ministry of foreign affairs of the People's Republic ofChina has purchased 700,000 boxes of Lianhua Qingwen and distribute them to eachChinese embassy. The health packages ...

2020-04-13 22:25 2642

Yiling Pharmaceutical Lianhua Qingwen capsules are widely used in China against the epidemic

SHIJIAZHUANG, China, April 13, 2020 /PRNewswire/ -- Wu Xiangjun, general manager of Yiling Pharmaceutical co., LTD., announced thatLianhua Qingwen capsules (granules) have been recommended by the National Health Commission and the State Administration of Traditional Medicine of China. The ministr...

2020-04-13 21:55 1990

Seegene Receives Health Canada Approval for its COVID-19 Assay

SEOUL, South Korea, April 13, 2020 /PRNewswire/ -- Seegene, Inc. announced that Health Canada (HC) authorized an interim order which allows the import and sale inCanada of Seegene's Allplex™ 2019-nCoV Assay, a Real-time RT-PCR test for SARS-CoV-2, the novel coronavirus responsible for the COVI...

2020-04-13 21:00 2300

Gracell to Present the First-in-human, Universal TruUCAR™ GC027 Therapy for Relapsed or Refractory T-cell Acute Lymphoblastic Leukemia at the AACR Annual Meeting

SUZHOU, China and SHANGHAI, April 13, 2020 /PRNewswire/ -- Gracell Biotechnologies Co., Ltd. ("Gracell"), a clinical-stage immune cell and gene therapy company, is pleased to announce that their first-in-human phase I data of UniversalTruUCAR™ GC027 in relapsed or refractory (R/R) T-cell acute l...

2020-04-13 21:00 1288
1 ... 579580581582583584585 ... 610

Week's Top Stories